- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Cangene Corporation
Total 8475 results
-
University of California, San FranciscoCelgene CorporationCompletedAdenocarcinoma | Pancreatic Neoplasms | Pancreatic CancerUnited States
-
Chronic Lymphocytic Leukemia Research ConsortiumCelgene CorporationUnknownChronic Lymphocytic Leukemia | CLL | Untreated | First-Line | Front-line | Initial TherapyUnited States
-
Washington University School of MedicineCentene CorporationRecruiting
-
Muhammad FurqanCelgene CorporationActive, not recruitingSmall Cell Lung Cancer (SCLC)United States
-
Wuerzburg University HospitalCelgene Corporation; ClinAssess GmbHActive, not recruitingPreviously Untreated Symptomatic Multiple MyelomaGermany
-
M.D. Anderson Cancer CenterCelgene Corporation; AmgenCompletedBreast CancerUnited States
-
AIO-Studien-gGmbHCelgene Corporation; ClinAssess GmbHCompletedAdenocarcinoma of the Pancreas | Metastatic Pancreatic CancerGermany
-
Michael PfeilstöckerCelgene CorporationCompletedMyelodysplastic SyndromesAustria
-
Washington University School of MedicineCelgene CorporationCompleted
-
Washington University School of MedicineCelgene CorporationCompletedHodgkin DiseaseUnited States
-
UNC Lineberger Comprehensive Cancer CenterCelgene CorporationCompletedHead and Neck CancerUnited States
-
Kenneth AinCelgene CorporationCompletedThyroid NeoplasmsUnited States
-
Royal Marsden NHS Foundation TrustCelgene CorporationActive, not recruitingDiffuse Large B-Cell LymphomaUnited Kingdom
-
GERCOR - Multidisciplinary Oncology Cooperative...Celgene CorporationUnknown
-
Memorial Sloan Kettering Cancer CenterCelgene CorporationWithdrawnSolitary Bone PlasmacytomaUnited States
-
Washington University School of MedicineCelgene CorporationCompleted
-
Memorial Sloan Kettering Cancer CenterCelgene CorporationCompletedLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
The Methodist Hospital Research InstituteCelgene CorporationTerminatedProstatic NeoplasmsUnited States
-
PETHEMA FoundationRoche Pharma AG; Celgene CorporationTerminatedMyelodysplastic SyndromeSpain
-
New Mexico Cancer Care AllianceCelgene CorporationTerminatedOvarian Cancer | Epithelial Ovarian Cancer | Fallopian Tube Carcinoma | Primary Peritoneal CarcinomaUnited States
-
Peter MacCallum Cancer Centre, AustraliaCelgene CorporationUnknownMyelodysplasiaAustralia
-
Mt. Sinai Medical Center, MiamiCelgene CorporationCompletedColorectal CancerUnited States
-
Korean Multiple Myeloma Working PartyCelgene CorporationUnknownMultiple MyelomaKorea, Republic of
-
Washington University School of MedicineCelgene CorporationActive, not recruitingHead and Neck Cancer | Squamous Cell Carcinoma of the Head and Neck | Cancer of Head and Neck | Neoplasms, Head and Neck | Cancer of the Head and Neck | Carcinoma, Squamous Cell of the Head and NeckUnited States
-
University of California, San DiegoCelgene CorporationCompletedChronic Lymphocytic Leukemia | CLLUnited States
-
Washington University School of MedicineCelgene CorporationActive, not recruitingHead and Neck Cancer | Head and Neck Squamous Cell Carcinoma | Cancer of the Head and NeckUnited States
-
Memorial Sloan Kettering Cancer CenterCelgene CorporationCompletedProstate Cancer | Castration Resistant Prostate CancerUnited States
-
Washington University School of MedicineCelgene CorporationCompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Oregon Health and Science UniversityCelgene CorporationCompletedAtopic Dermatitis
-
University of Kansas Medical CenterCelgene CorporationCompleted
-
The Lymphoma Academic Research OrganisationCelgene CorporationCompletedRelapsed/Refractory B-cell LymphomaFrance
-
Memorial Sloan Kettering Cancer CenterCelgene CorporationWithdrawnLymphoma | Follicular Lymphoma
-
Peter MacCallum Cancer Centre, AustraliaCelgene CorporationUnknown
-
Southern Europe New Drug OrganizationCelgene CorporationUnknown
-
Washington University School of MedicineCelgene CorporationCompleted
-
Korean Multiple Myeloma Working PartyCelgene CorporationUnknown
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationActive, not recruitingPrimary Myelofibrosis | Myelofibrosis | Post-Polycythemia VeraAustralia, Austria, Belgium, China, Czechia, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, Ireland, United Kingdom
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationCompletedPrimary Myelofibrosis | Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States, Canada
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationCompletedHealthy Volunteers | Hepatic ImpairmentUnited States
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationCompleted
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationAvailable
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationCompletedHealthy VolunteersUnited States
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationCompletedHealthy VolunteersUnited States
-
GenMont Biotech IncorporationBiomedical Development CorporationCompletedProbiotics | Perennial Allergic Rhinitis | Lactobacillus Paracasei GMNL-32 (eN-Lac®)Taiwan
-
Weill Medical College of Cornell UniversityCelgene CorporationCompletedPreviously Untreated Peripheral T-cell LymphomaUnited States
-
Institut CurieCelgene Corporation; Intergroupe Francophone du MyelomeCompleted
-
University of Wisconsin, MadisonGenentech, Inc.; Celgene CorporationCompletedLymphoma, Non-Hodgkin | Small Lymphocytic Lymphoma | Lymphoid LeukemiaUnited States
-
Pharmacyclics LLC.Janssen Research & Development, LLC; Celgene CorporationCompletedRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited States, United Kingdom, Belgium, Germany
-
Weill Medical College of Cornell UniversityCelgene CorporationTerminatedWaldenstrom MacroglobulinemiaUnited States
-
Weill Medical College of Cornell UniversityCelgene CorporationTerminatedMultiple MyelomaUnited States